Concepedia

Publication | Closed Access

Safety and Pharmacokinetics of Ribavirin for the Treatment of La Crosse Encephalitis

38

Citations

27

References

2011

Year

Abstract

Although the results do not support the use of RBV for LACVE, this nevertheless is the largest study of antiviral treatment for LACVE to date and the largest pharmacokinetic analysis of IV RBV in children for any indication.

References

YearCitations

Page 1